Healthcare Stocks

Researchers test mRNA technology for universal flu vaccine

  • November 26, 2022 10:00 AM PST | Reuters
 Researchers test mRNA technology for universal flu vaccine

By Nancy Lapid (Reuters) - An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway

Read More...

BRIEF-Natera Says Public Offering Of 11.43 Mln Shares At $35/Share

BRIEF-Natera Says Public Offering Of 11.43 Mln Shares At $35/Share

  • November 16, 2022 03:04 PM PST | Reuters

Nov 15 (Reuters) - Natera Inc: * NATERA ANNOUNCES PRICING OF FOLLOW-ON OFFERING * NATERA INC SAYS PUBLIC OFFERING OF 11.43 MILLION COMMON SHARES PRICED AT $35.00PER SHARE Source text for Eikon:

Read More...
SINTX Technologies Inc <SINT.O>: Losses of 11  cents announced for third quarter

SINTX Technologies Inc <SINT.O>: Losses of 11  cents announced for third quarter

  • November 16, 2022 01:54 PM PST | Reuters

16 November 2022 02:54 a.m. ​All figures in US dollars. The loss announced by SINTX Technologies Inc in the third quarter were on par with the Refinitiv mean estimate of losses. The company reported

Read More...
SINTX Technologies Inc reports results for the quarter ended in September - Earnings Summary

SINTX Technologies Inc reports results for the quarter ended in September - Earnings Summary

  • November 16, 2022 01:54 PM PST | Reuters

* SINTX Technologies Inc reported a quarterly adjusted loss of 11 cents​​ per share for the quarter ended in September. The mean expectation of two analysts for the quarter was for a loss of 11 cents

Read More...
BRIEF-Burning Rock Reports Third Quarter Loss Per Share $0.31

BRIEF-Burning Rock Reports Third Quarter Loss Per Share $0.31

  • November 16, 2022 01:24 PM PST | Reuters

Nov 15 (Reuters) - Burning Rock Biotech Ltd: * BURNING ROCK REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS * Q3 REVENUES WERE RMB154.6 MILLION (US$21.7 MILLION) A 22.1% INCREASE FROM RMB126.6 MILLION

Read More...
EUROPE RESEARCH ROUNDUP-Ashtead Technology Holdings, Delivery Hero, Kainos

EUROPE RESEARCH ROUNDUP-Ashtead Technology Holdings, Delivery Hero, Kainos

  • November 16, 2022 09:12 PM GMT | Reuters

Nov 16 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Ashtead Technology Holdings, Delivery Hero, and Kainos, on Wednesday. HIGHLIGHTS

Read More...
EUROPE RESEARCH ROUNDUP-Ashtead Technology Holdings, Delivery Hero, Kainos

EUROPE RESEARCH ROUNDUP-Ashtead Technology Holdings, Delivery Hero, Kainos

  • November 16, 2022 09:12 PM WET | Reuters

Nov 16 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Ashtead Technology Holdings, Delivery Hero, and Kainos, on Wednesday. HIGHLIGHTS

Read More...
BRIEF-Ascletis Pharma Announces IND Approval Of ASC10 For Monkeypox Indication By U.S. FDA

BRIEF-Ascletis Pharma Announces IND Approval Of ASC10 For Monkeypox Indication By U.S. FDA

  • November 16, 2022 12:23 PM PST | Reuters

Nov 16 (Reuters) - Ascletis Pharma Inc: * ANNOUNCES IND APPROVAL OF ASC10 FOR MONKEYPOX INDICATION BY U.S. FDA Source text for Eikon: Further company coverage:

Read More...
EUROPE RESEARCH ROUNDUP-Ashtead Technology Holdings, Delivery Hero, Kainos

EUROPE RESEARCH ROUNDUP-Ashtead Technology Holdings, Delivery Hero, Kainos

  • November 16, 2022 09:12 PM CET | Reuters

Nov 16 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Ashtead Technology Holdings, Delivery Hero, and Kainos, on Wednesday. HIGHLIGHTS

Read More...
EUROPE RESEARCH ROUNDUP-Ashtead Technology Holdings, Delivery Hero, Kainos

EUROPE RESEARCH ROUNDUP-Ashtead Technology Holdings, Delivery Hero, Kainos

  • November 16, 2022 09:12 PM CET | Reuters

Nov 16 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Ashtead Technology Holdings, Delivery Hero, and Kainos, on Wednesday. HIGHLIGHTS

Read More...
EUROPE RESEARCH ROUNDUP-Ashtead Technology Holdings, Delivery Hero, Kainos

EUROPE RESEARCH ROUNDUP-Ashtead Technology Holdings, Delivery Hero, Kainos

  • November 16, 2022 09:12 PM CET | Reuters

Nov 16 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Ashtead Technology Holdings, Delivery Hero, and Kainos, on Wednesday. HIGHLIGHTS

Read More...

Frequently Asked Questions

Healthcare stocks are companies involved in the healthcare industry. These companies are engaged in manufacturing. Various pharmaceutical products, including medicine, medical devices, medical care through hospitals and medical centres, health insurance, etc. Despite stock market risks, healthcare stocks can provide substantial returns in the long run. The healthcare sector has been one of the top-performing sectors over the past year. The covid-19 pandemic has accelerated its growth. Some of the top healthcare stocks include Walgreens Boots Alliance Inc. (WBA), Sage Therapeutics Inc. (SAGE), Bio-Rad Laboratories Inc. (BIO), Pfizer Inc, Moderna Inc, etc.

The healthcare sector is one of the largest and most complex sectors in the US, which is comprised of various companies that engage in a wide range of healthcare-related operations. Some of the top healthcare stocks in the US are as follows: UnitedHealth Group Inc. (UNH) Johnson & Johnson (JNJ) Pfizer Inc (PFE) Abbvie Inc (ABBV) Eli Lilly and Co (LLY)

The healthcare sector is one of the centers of attraction of investors in recent days, especially considering the growth potentials of the companies. Some of the best US healthcare stocks are as follows, that maintained has maintained a steady momentum even amid the market downturn. Johnson & Johnson (JNJ) Abbvie Inc (ABBV) Eli Lilly and Co (LLY) Merck & Co Inc (MRK) Bristol-Myers Squibb Co (BMY)

AI healthcare stocks are companies that use artificial intelligence to provide tailor-made products and services to the healthcare industry. The innovation in AI healthcare companies is rapidly transforming the industry. Their help to understand and classify clinical documentation, clinical notes on patients, and insight into methods for better results.